Speed up diagnostics AXDX reported fourth quarter earnings results on Thursday, March 28, 2024 at 4:05 pm.
Here’s what investors need to know about the announcement.
Earnings
Accelerate Diagnostics missed estimated earnings by -44.0%, reporting EPS of -$0.89 versus an estimate of -$0.62.
Revenues increased by $55,000 compared to the same period last year.
Past earnings performance
In the last quarter the company missed EPS by $0.11, followed by a 3.0% drop in the stock price the next day.
Here’s a look at Accelerate Diagnostics’ past performance:
| Quarter | Third quarter 2023 | Second quarter 2023 | First quarter 2023 | Fourth quarter 2022 |
|---|---|---|---|---|
| EPS estimate | -1.07 | -1.40 | -1.4 | -1.5 |
| Actual EPS | -1.18 | -1.31 | -1.7 | -1.5 |
| Revenue estimate | 3.53 million | 3.60 million | 3.35 million | 2.87 million |
| Actual revenue | 3.30 million | 2.92 million | 2.81 million | 2.97 million |
To track all earnings releases for Accelerate Diagnostics, visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade with confidence with insights and alerts from analyst ratings, free reports and breaking news on the stocks you care about.